MODEL VERDICT
MacroGenics, Inc. (MGNX)
Relative Valuation•Peer multiples, Monte Carlo simulation & quality-adjusted fair value
Popular:
Composite score derived from valuation, quality, and risk factors
Quantitative model thresholds · For educational and research purposes only
| Methodology | Fair Value | vs Current | Weight | Quality | Status |
|---|---|---|---|---|---|
| EV To Revenue 182 industry peers | $20.44 | +1035.6% | 4% | B | Data |
| Price / Sales 184 industry peers | $17.03 | +846.1% | 3% | B | Model Driven |
| Weighted Output Blended model output | $18.15 | +908.5% | 100% | 60 | SIGNIFICANTLY UNDERVALUED |
Cross-sectional regression predicting expected multiples based on growth, margins, ROIC, and beta.
| Multiple | Avg | Median | Min | Max | Std |
|---|---|---|---|---|---|
| P/TBV | 3.00 | 2.90 | 1.75 | 4.05 | 0.98 |
| P/B Ratio | 3.00 | 2.90 | 1.75 | 4.05 | 0.98 |
| P/S Ratio | 8.09 | 8.65 | 1.37 | 12.72 | 4.44 |
Based on our peer multiples analysis with 5 valuation metrics, the model estimates MGNX's fair value at $18.15 vs the current price of $1.80, implying +908.5% upside potential. Model verdict: Significantly Undervalued. Confidence: 60/100. This is a quantitative estimate, not a recommendation.
The blended fair value of $18.15 is calculated using four lenses: industry median multiples (40%), historical multiples (30%), forward estimates (20%), and quality-adjusted multiples (10%).
MGNX's current P/E of -1.7x compares to the industry median of 23.5x (45 peers in the group). This represents a -107.2% discount to the industry. The historical average P/E is N/Ax over 0 years. Signal: Deep Discount.
22 analysts cover MGNX with a consensus rating of Buy. The consensus price target is $9.44 (range: $2.00 — $32.00), implying +424.4% upside from the current price. Grade breakdown: Strong Buy (0), Buy (11), Hold (10), Sell (1), Strong Sell (0).
The model confidence score is 60/100, based on: data completeness (3), peer quality (25), historical depth (20), earnings stability (5), and model agreement (7). Cyclicality penalty: -0 points. The model shows moderate agreement across inputs.
The model flags several key risks: (1) Macro/regulatory risks are not captured in this model but remain material.
Peak earnings risk data is not available for MGNX.
No. This dashboard is a quantitative research tool for educational and informational purposes only. It is not investment advice, a solicitation, or a recommendation to buy, sell, or hold any security. The operator of this platform is not a registered investment advisor (RIA), broker-dealer, or financial planner. All model outputs, fair value estimates, signals, and scenarios are the result of automated quantitative computations and should not be construed as professional financial guidance. You should consult a qualified, licensed financial advisor before making any investment decisions. Past model performance is not indicative of future results.